COVID-19 vaccine | US approves third dose of Pfizer and Moderna for 18+

The United States on Friday extended authorization for booster vaccines against COVID-19 to all people over 18 years of age, six months after completing their primary vaccination series, health authorities announced.

SIGHT: A fish vendor from Wuhan market is the first known case of COVID-19, study reveals

The Food and Drug Administration (FDA) said the emergency use authorization granted to Pfizer and Moderna laboratories helped “, even against the serious consequences that can occur, such as hospitalization or death ”.

The two drug companies had announced shortly before that they had obtained FDA approval.

SIGHT: COVID-19 | Masks, confinement and hand washing: are there more effective measures than others?

“This emergency use authorization comes at a critical time as we enter the winter months and face a number of and hospitalizations throughout the country “said Moderna CEO Stephane Bancel.

People over the age of 18 who received the Johnson & Johnson single-dose vaccine in the United States were already entitled to a second dose, two months after their first injection.

SIGHT: Immunotherapy with killed bacteria reduces mortality and boosts vaccines against COVID-19

In the case of those vaccinated with Pfizer and Moderna, the third dose was reserved until now only for certain categories of people:, adults at risk of developing a severe form of the disease or those with high exposure to the virus, for example through your work.

This announcement comes at a time when cases are on the rise again in the United States, with an average of 85,000 new cases of COVID-19 each day (up from about 70,000 at the end of October), and about 1,000 deaths a day. .

Some states in the United States, including California (western), had already begun allowing booster doses for all adults, even before the r, in hopes of containing the spread of the epidemic before the holiday season.

• A fish vendor from Wuhan market is the first known case of COVID-19, study reveals
• COVID-19 | Masks, confinement and hand washing: are there more effective measures than others?
• Immunotherapy with killed bacteria reduces mortality and boosts vaccines against COVID-19
• Pfizer and Moderna vaccines may give false positives for COVID-19
• AstraZeneca Antibody Drug 83% Protects Against COVID-19 for Six Months
• Pfizer and Moderna vaccines may give false positives for COVID-19
• How is the first drug against COVID-19 that China would have ready in December?
• 82% of COVID-19 cases in Peru are detected in unvaccinated people
• Why China maintains its goal of not registering any coronavirus infection
• Pfizer agrees to facilitate global access of its COVID-19 pill
• COVID-19 | Italy raids anti-vaccines for promoting violence on the internet
• COVID-19 | What is Austria looking for by confining only the unvaccinated?
• Is persistent COVID-19 mostly in the head? A study generates controversy
• The future of the pandemic is here, by Elmer Huerta
• EMA approves Ronapreve and Regkirona treatments for COVID-19
• The gene that is linked to some people suffering from a more serious COVID-19
• COVID-19 | In what phase is the approval of the Sputnik V vaccine in the WHO?
• COVID-19 | Scientists identify the Delta variant mutation that makes it so contagious
• COVID-19 | What the second generation of vaccines will look like and why they are important
• COVID-19 pandemic will only end if vaccination is “mandatory”, says creator of Sputnik V

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn